93 related articles for article (PubMed ID: 22864777)
21. P53 mutations in colorectal cancer from northern Iran: Relationships with site of tumor origin, microsatellite instability and K-ras mutations.
Mahdavinia M; Bishehsari F; Verginelli F; Cumashi A; Lattanzio R; Sotoudeh M; Ansari R; Semeraro D; Hormazdi M; Fakheri H; Rakhshani N; De Lellis L; Curia MC; Cama A; Piantelli M; Malekzadeh R; Iacobelli S; Mariani-Costantini R
J Cell Physiol; 2008 Aug; 216(2):543-50. PubMed ID: 18330889
[TBL] [Abstract][Full Text] [Related]
22. Ki-ras mutation and p53 overexpression predict the clinical behavior of colorectal cancer: a Southwest Oncology Group study.
Ahnen DJ; Feigl P; Quan G; Fenoglio-Preiser C; Lovato LC; Bunn PA; Stemmerman G; Wells JD; Macdonald JS; Meyskens FL
Cancer Res; 1998 Mar; 58(6):1149-58. PubMed ID: 9515799
[TBL] [Abstract][Full Text] [Related]
23. [Significance of K-ras detection in colorectal cancer].
Xu XM; Zhang GL; Li MW; Wang DY; Lin JJ
Zhonghua Yi Xue Za Zhi; 2010 May; 90(18):1268-71. PubMed ID: 20646601
[TBL] [Abstract][Full Text] [Related]
24. Sensitive detection of K-ras mutations augments diagnosis of colorectal cancer metastases in the liver.
Schimanski CC; Linnemann U; Berger MR
Cancer Res; 1999 Oct; 59(20):5169-75. PubMed ID: 10537293
[TBL] [Abstract][Full Text] [Related]
25. K-ras gene mutation is a useful predictor of the survival of early stage colorectal cancers.
Lee JC; Wang ST; Lai MD; Lin YJ; Yang HB
Anticancer Res; 1996; 16(6B):3839-44. PubMed ID: 9042267
[TBL] [Abstract][Full Text] [Related]
26. Laterally spreading type of colorectal adenoma exhibits a unique methylation phenotype and K-ras mutations.
Hiraoka S; Kato J; Tatsukawa M; Harada K; Fujita H; Morikawa T; Shiraha H; Shiratori Y
Gastroenterology; 2006 Aug; 131(2):379-89. PubMed ID: 16890591
[TBL] [Abstract][Full Text] [Related]
27. Mutation pattern of K-ras gene in colorectal cancer patients of Kashmir: a report.
Sameer AS; Chowdhri NA; Abdullah S; Shah ZA; Siddiqi MA
Indian J Cancer; 2009; 46(3):219-25. PubMed ID: 19574674
[TBL] [Abstract][Full Text] [Related]
28. Ischemia-induced K-ras mutations in human colorectal cancer cells: role of microenvironmental regulation of MSH2 expression.
Shahrzad S; Quayle L; Stone C; Plumb C; Shirasawa S; Rak JW; Coomber BL
Cancer Res; 2005 Sep; 65(18):8134-41. PubMed ID: 16166287
[TBL] [Abstract][Full Text] [Related]
29. Tissue sampling for mutation analysis in colorectal cancer: K-ras is homogeneously distributed throughout the tumor tissue.
Ekelund S; Papadogiannakis N; Olivecrona H; Lindforss U
Oncol Rep; 2011 Jan; 25(1):253-8. PubMed ID: 21109984
[TBL] [Abstract][Full Text] [Related]
30. Keratin 20 is a specific marker of submicroscopic lymph node metastases in colorectal cancer: validation by K-RAS mutations.
Yun K; Merrie AE; Gunn J; Phillips LV; McCall JL
J Pathol; 2000 May; 191(1):21-6. PubMed ID: 10767714
[TBL] [Abstract][Full Text] [Related]
31. Systematic analysis of proteins from different signaling pathways in the tumor center and the invasive front of colorectal cancer.
Karamitopoulou E; Zlobec I; Panayiotides I; Patsouris ES; Peros G; Rallis G; Lapas C; Karakitsos P; Terracciano LM; Lugli A
Hum Pathol; 2011 Dec; 42(12):1888-96. PubMed ID: 21664646
[TBL] [Abstract][Full Text] [Related]
32. Cyclin D1 overexpression in colorectal carcinoma in vivo is dependent on beta-catenin protein dysregulation, but not k-ras mutation.
Wong NA; Morris RG; McCondochie A; Bader S; Jodrell DI; Harrison DJ
J Pathol; 2002 May; 197(1):128-35. PubMed ID: 12081197
[TBL] [Abstract][Full Text] [Related]
33. Decreased expression of the RAS-GTPase activating protein RASAL1 is associated with colorectal tumor progression.
Ohta M; Seto M; Ijichi H; Miyabayashi K; Kudo Y; Mohri D; Asaoka Y; Tada M; Tanaka Y; Ikenoue T; Kanai F; Kawabe T; Omata M
Gastroenterology; 2009 Jan; 136(1):206-16. PubMed ID: 18992247
[TBL] [Abstract][Full Text] [Related]
34. Frequent involvement of ras-signalling pathways in both polypoid-type and flat-type early-stage colorectal cancers.
Noda H; Kato Y; Yoshikawa H; Arai M; Togashi K; Nagai H; Konishi F; Miki Y
J Exp Clin Cancer Res; 2006 Jun; 25(2):235-42. PubMed ID: 16918136
[TBL] [Abstract][Full Text] [Related]
35. PIK3CA mutation is predictive of poor survival in patients with colorectal cancer.
Kato S; Iida S; Higuchi T; Ishikawa T; Takagi Y; Yasuno M; Enomoto M; Uetake H; Sugihara K
Int J Cancer; 2007 Oct; 121(8):1771-8. PubMed ID: 17590872
[TBL] [Abstract][Full Text] [Related]
36. Activation of extracellular regulated kinases (ERK1/2) but not AKT predicts poor prognosis in colorectal carcinoma and is associated with k-ras mutations.
Schmitz KJ; Wohlschlaeger J; Alakus H; Bohr J; Stauder MA; Worm K; Winde G; Schmid KW; Baba HA
Virchows Arch; 2007 Feb; 450(2):151-9. PubMed ID: 17149612
[TBL] [Abstract][Full Text] [Related]
37. Somatic mutations, acetylator status, and prognosis in colorectal cancer.
Hardingham JE; Butler WJ; Roder D; Dobrovic A; Dymock RB; Sage RE; Roberts-Thomson IC
Gut; 1998 May; 42(5):669-72. PubMed ID: 9659162
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of K-RAS gene in colorectal cancer.
Okulczyk B; Piotrowski Z; Kovalchuk O; Nikliński J; Chyczewski L
Folia Histochem Cytobiol; 2003; 41(2):97-100. PubMed ID: 12722796
[TBL] [Abstract][Full Text] [Related]
39. K-ras gene mutation as an early prognostic marker of colon cancer.
Szpon Ł; Stal A; Zawadzki M; Lis-Nawara A; Kielan W; Grzebieniak Z
Pol Przegl Chir; 2016 Jan; 88(1):15-9. PubMed ID: 27096769
[TBL] [Abstract][Full Text] [Related]
40. Increased farnesyltransferase activity in human colorectal cancer: relationship with clinicopathological features and K-ras mutation.
Caruso MG; Notarnicola M; Bifulco M; Laezza C; Guerra V; Altomare DF; Memeo V; Lorusso D; Demma I; Di Leo A
Scand J Gastroenterol; 2003 Jan; 38(1):80-5. PubMed ID: 12608469
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
